NLS Pharmaceutics Ltd. Warrant (NLSPW) Key Ratios
$0.02
$0.00 (0.00%)As on 25-Nov-2025 16:00EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | -- | -13.93 | 69.20 | 19.19 | 3.96 |
| Net Profit | -- | -9.08 | 83.73 | 22.41 | 10.35 |
| EPS | -- | -1,042.40 | 85.19 | 12.32 | 13.74 |
| Book Value | -- | -- | -- | 108.91 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Dec-24 | Dec-23 | Dec-22 |
| EBIT-Margin
| -- | -- | -- | -- | -- |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| -123.72 | -10.07 | 53.34 | 438.42 | -862.92 |
| Return on Capital
| -57.78 | 49.86 | 68.38 | 621.18 | -862.92 |
| Return on Assets
| -178.43 | -235.54 | -97.10 | -218.86 | -219.34 |
| Debt to Equity (x)
| -- | -- | -- | -0.18 | -- |
The underlying data is unavailable.